ADVERTISEMENT
Quiz
Phase 3 Data Reveal RSV Vaccine's Efficacy and Safety
Maria Asimopoulos
03/31/2023
The RSVPreF3 OA vaccine is being tested in an ongoing, international, phase 3 trial with participants aged 60 years and older. Researchers recently reported efficacy and safety data.
Advertisement
Advertisement
Advertisement
Current Issue
June 2024
Volume 21
Issue 2
Advertisement
Advertisement
What's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter